Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

ARMP vs SIGA

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ARMP
Armata Pharmaceuticals, Inc.

Biotechnology

AMEX • US
Market Cap$304M
5Y Perf.+123.1%
SIGA
SIGA Technologies, Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • US
Market Cap$344M
5Y Perf.-19.9%

ARMP vs SIGA — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ARMP logoARMP
SIGA logoSIGA
IndustryBiotechnologyDrug Manufacturers - Specialty & Generic
Market Cap$304M$344M
Revenue (TTM)$5M$94M
Net Income (TTM)$-174M$-4.04T
Gross Margin68.8%61.8%
Operating Margin-6.4%27.7%
Forward P/E2.8x
Total Debt$288M$595K
Cash & Equiv.$9M$155M

ARMP vs SIGALong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ARMP
SIGA
StockMay 20May 26Return
Armata Pharmaceutic… (ARMP)100223.1+123.1%
SIGA Technologies, … (SIGA)10080.1-19.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: ARMP vs SIGA

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ARMP and SIGA are tied at the top with 3 categories each — the right choice depends on your priorities. SIGA Technologies, Inc. is the stronger pick specifically for capital preservation and lower volatility and dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
ARMP
Armata Pharmaceuticals, Inc.
The Growth Play

ARMP carries the broadest edge in this set and is the clearest fit for growth exposure.

  • Rev growth -5.2%, EPS growth -8.2%, 3Y rev CAGR -3.8%
  • -5.2% revenue growth vs SIGA's -31.8%
  • -35.4% margin vs SIGA's -43K%
Best for: growth exposure
SIGA
SIGA Technologies, Inc.
The Income Pick

SIGA is the clearest fit if your priority is income & stability and long-term compounding.

  • Dividend streak 4 yrs, beta 1.09, yield 12.5%
  • 7.7% 10Y total return vs ARMP's -97.6%
  • Lower volatility, beta 1.09, Low D/E 0.3%, current ratio 11.83x
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthARMP logoARMP-5.2% revenue growth vs SIGA's -31.8%
Quality / MarginsARMP logoARMP-35.4% margin vs SIGA's -43K%
Stability / SafetySIGA logoSIGABeta 1.09 vs ARMP's 1.24
DividendsSIGA logoSIGA12.5% yield; 4-year raise streak; the other pay no meaningful dividend
Momentum (1Y)ARMP logoARMP+5.1% vs SIGA's -0.7%
Efficiency (ROA)SIGA logoSIGA-7.4% ROA vs ARMP's -207.9%, ROIC 33.7% vs -36.0%

ARMP vs SIGA — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ARMPArmata Pharmaceuticals, Inc.

Segment breakdown not available.

SIGASIGA Technologies, Inc.
FY 2025
Product Sales and Supportive Services
93.1%$88M
Research and Development
6.9%$7M

ARMP vs SIGA — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLSIGALAGGINGARMP

Income & Cash Flow (Last 12 Months)

SIGA leads this category, winning 3 of 5 comparable metrics.

SIGA is the larger business by revenue, generating $94M annually — 19.1x ARMP's $5M. ARMP is the more profitable business, keeping -35.4% of every revenue dollar as net income compared to SIGA's -43117.4%.

MetricARMP logoARMPArmata Pharmaceut…SIGA logoSIGASIGA Technologies…
RevenueTrailing 12 months$5M$94M
EBITDAEarnings before interest/tax-$30M$26M
Net IncomeAfter-tax profit-$174M-$4.04T
Free Cash FlowCash after capex-$26M$27M
Gross MarginGross profit ÷ Revenue+68.8%+61.8%
Operating MarginEBIT ÷ Revenue-6.4%+27.7%
Net MarginNet income ÷ Revenue-35.4%-43117.4%
FCF MarginFCF ÷ Revenue-5.4%+29.2%
Rev. Growth (YoY)Latest quarter vs prior year-12.1%-11.3%
EPS Growth (YoY)Latest quarter vs prior year-79.0%
SIGA leads this category, winning 3 of 5 comparable metrics.

Valuation Metrics

Evenly matched — ARMP and SIGA each lead in 1 of 2 comparable metrics.
MetricARMP logoARMPArmata Pharmaceut…SIGA logoSIGASIGA Technologies…
Market CapShares × price$304M$344M
Enterprise ValueMkt cap + debt − cash$583M$190M
Trailing P/EPrice ÷ TTM EPS-1.73x14.55x
Forward P/EPrice ÷ next-FY EPS est.2.82x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple7.81x
Price / SalesMarket cap ÷ Revenue62.00x3.64x
Price / BookPrice ÷ Book value/share1.73x
Price / FCFMarket cap ÷ FCF7.98x
Evenly matched — ARMP and SIGA each lead in 1 of 2 comparable metrics.

Profitability & Efficiency

SIGA leads this category, winning 6 of 6 comparable metrics.

On the Piotroski fundamental quality scale (0–9), SIGA scores 5/9 vs ARMP's 4/9, reflecting solid financial health.

MetricARMP logoARMPArmata Pharmaceut…SIGA logoSIGASIGA Technologies…
ROE (TTM)Return on equity-10.7%
ROA (TTM)Return on assets-2.1%-7.4%
ROICReturn on invested capital-36.0%+33.7%
ROCEReturn on capital employed-58.8%+11.3%
Piotroski ScoreFundamental quality 0–945
Debt / EquityFinancial leverage0.00x
Net DebtTotal debt minus cash$279M-$154M
Cash & Equiv.Liquid assets$9M$155M
Total DebtShort + long-term debt$288M$595,169
Interest CoverageEBIT ÷ Interest expense-1.88x
SIGA leads this category, winning 6 of 6 comparable metrics.

Total Returns (Dividends Reinvested)

ARMP leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in ARMP five years ago would be worth $20,244 today (with dividends reinvested), compared to $10,791 for SIGA. Over the past 12 months, ARMP leads with a +510.3% total return vs SIGA's -0.7%. The 3-year compound annual growth rate (CAGR) favors ARMP at 83.7% vs SIGA's 7.3% — a key indicator of consistent wealth creation.

MetricARMP logoARMPArmata Pharmaceut…SIGA logoSIGASIGA Technologies…
YTD ReturnYear-to-date+26.5%-13.9%
1-Year ReturnPast 12 months+510.3%-0.7%
3-Year ReturnCumulative with dividends+519.4%+23.5%
5-Year ReturnCumulative with dividends+102.4%+7.9%
10-Year ReturnCumulative with dividends-97.6%+772.1%
CAGR (3Y)Annualised 3-year return+83.7%+7.3%
ARMP leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — ARMP and SIGA each lead in 1 of 2 comparable metrics.

SIGA is the less volatile stock with a 1.09 beta — it tends to amplify market swings less than ARMP's 1.24 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.

MetricARMP logoARMPArmata Pharmaceut…SIGA logoSIGASIGA Technologies…
Beta (5Y)Sensitivity to S&P 5001.24x1.09x
52-Week HighHighest price in past year$16.34$9.62
52-Week LowLowest price in past year$1.17$4.29
% of 52W HighCurrent price vs 52-week peak+50.8%+49.9%
RSI (14)Momentum oscillator 0–10042.048.5
Avg Volume (50D)Average daily shares traded50K703K
Evenly matched — ARMP and SIGA each lead in 1 of 2 comparable metrics.

Analyst Outlook

SIGA leads this category, winning 1 of 1 comparable metric.

Wall Street rates ARMP as "Buy" and SIGA as "Buy". SIGA is the only dividend payer here at 12.54% yield — a key consideration for income-focused portfolios.

MetricARMP logoARMPArmata Pharmaceut…SIGA logoSIGASIGA Technologies…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$15.00
# AnalystsCovering analysts41
Dividend YieldAnnual dividend ÷ price+12.5%
Dividend StreakConsecutive years of raises04
Dividend / ShareAnnual DPS$0.60
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
SIGA leads this category, winning 1 of 1 comparable metric.
Key Takeaway

SIGA leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ARMP leads in 1 (Total Returns). 2 tied.

Best OverallSIGA Technologies, Inc. (SIGA)Leads 3 of 6 categories
Loading custom metrics...

ARMP vs SIGA: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is ARMP or SIGA a better buy right now?

For growth investors, Armata Pharmaceuticals, Inc.

(ARMP) is the stronger pick with -5. 2% revenue growth year-over-year, versus -31. 8% for SIGA Technologies, Inc. (SIGA). SIGA Technologies, Inc. (SIGA) offers the better valuation at 14. 5x trailing P/E (2. 8x forward), making it the more compelling value choice. Analysts rate Armata Pharmaceuticals, Inc. (ARMP) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — ARMP or SIGA?

Over the past 5 years, Armata Pharmaceuticals, Inc.

(ARMP) delivered a total return of +102. 4%, compared to +7. 9% for SIGA Technologies, Inc. (SIGA). Over 10 years, the gap is even starker: SIGA returned +772. 1% versus ARMP's -97. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — ARMP or SIGA?

By beta (market sensitivity over 5 years), SIGA Technologies, Inc.

(SIGA) is the lower-risk stock at 1. 09β versus Armata Pharmaceuticals, Inc. 's 1. 24β — meaning ARMP is approximately 14% more volatile than SIGA relative to the S&P 500.

04

Which is growing faster — ARMP or SIGA?

By revenue growth (latest reported year), Armata Pharmaceuticals, Inc.

(ARMP) is pulling ahead at -5. 2% versus -31. 8% for SIGA Technologies, Inc. (SIGA). On earnings-per-share growth, the picture is similar: SIGA Technologies, Inc. grew EPS -60. 2% year-over-year, compared to -817. 6% for Armata Pharmaceuticals, Inc.. Over a 3-year CAGR, ARMP leads at -3. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — ARMP or SIGA?

SIGA Technologies, Inc.

(SIGA) is the more profitable company, earning 24. 6% net margin versus -35. 4% for Armata Pharmaceuticals, Inc. — meaning it keeps 24. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SIGA leads at 25. 1% versus -636. 7% for ARMP. At the gross margin level — before operating expenses — ARMP leads at 68. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — ARMP or SIGA?

In this comparison, SIGA (12.

5% yield) pays a dividend. ARMP does not pay a meaningful dividend and should not be held primarily for income.

07

Is ARMP or SIGA better for a retirement portfolio?

For long-horizon retirement investors, SIGA Technologies, Inc.

(SIGA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 09), 12. 5% yield, +772. 1% 10Y return). Both have compounded well over 10 years (SIGA: +772. 1%, ARMP: -97. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between ARMP and SIGA?

Both stocks operate in the null sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: ARMP is a small-cap quality compounder stock; SIGA is a small-cap deep-value stock. SIGA pays a dividend while ARMP does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

ARMP

Quality Business

  • Market Cap > $100B
  • Gross Margin > 41%
Run This Screen
Stocks Like

SIGA

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 37%
  • Dividend Yield > 5.0%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform ARMP and SIGA on the metrics below

Revenue Growth>
%
(ARMP: -12.1% · SIGA: -11.3%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.